2015 American Transplant Congress
Plasmapharesis, Intravenous Immunoglobulin and Rituximab Successfully Treat Recurrent Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2) After Liver Transplantation
Background:Allo-immune mediated BSEP dysfunction may occur after liver transplantation in PFIC2 patients leading to a PFIC2 like phenotype. The IgG antibodies are reactive toward a…2015 American Transplant Congress
Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases
1Transplantation, Mayo Clinic, Jacksonville, FL; 2Florida State University, Tallahassee, FL.
Background: Renal dysfunction in liver (LT) and liver-kidney (LKT) transplant candidates increases intraoperative risks of electrolyte disturbances and volume excess complications. The role of intraoperative…2015 American Transplant Congress
Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers
Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…2015 American Transplant Congress
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
BackgroundLiving donor liver transplantation (LDLT) has developed as an alternative to decease donor liver transplantation (DDLT) to overcome the critical shortage of deceased organ donations.…2015 American Transplant Congress
Pilot Study on Safety and Feasibility of Complete Meal Replacement in Liver Transplant Recipients and Potential Donors
Background: Metabolic syndrome (MS) and hepatic steatosis (HS) are potential long-term complications after liver transplantation (LT). Post-LT caloric intake normalizes which can result in obesity.…2015 American Transplant Congress
Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft
Background: Recent data suggests that patients with Hepatocellular carcinoma (HCC) who receive a donation after cardiac death (DCD) graft have inferior graft and patient survival…2015 American Transplant Congress
Effective Long-Term Prophylaxis against De Novo Hepatitis B With Hepatitis B Vaccination in Pediatric Recipients of HbcAb-Positive Liver Grafts
Department of Surgery, Samsung Medical Center, Seoul, Korea.
Background) Controversy still exists concerning the use of livers from hepatitis B surface antigen-negative (HBsAg-)/hepatitis B core antibody-positive (HBcAb+) donors for liver transplantation (LT). We…2015 American Transplant Congress
Toxoplasmosis Post-Kidney Or Liver Transplantation: A Serie of Cases
Toxoplasmosis is a rare complication post-SOT, occurring mostly in D+/R- mismatch. However, in highly endemic areas, the disease occurs predominantly in R+ under post-tx immunosuppressive…2015 American Transplant Congress
Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation
Background and Objective: Elevated plasma fibrinogen (FBG) level is associated with tumor progression and poor patient outcomes in several cancers. The aim of this study…2015 American Transplant Congress
Regional Mismatch Between Liver Supply and Demand: An Argument for a More Open Market
Background: Geographic disparities in liver transplantation (LT) are well recognized. But the degree to which regional variation in deceased donor deficits contributes to wait-list mortality…
- « Previous Page
- 1
- …
- 162
- 163
- 164
- 165
- 166
- …
- 180
- Next Page »